What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ:BPTH), a biotechnology company ...

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotech ...

Miss America 2024 winner Madison Marsh took her efforts to advocate for pancreatic cancer awareness and research to Capitol Hill on Thursday. In association with the Pancreatic Cancer ...

Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

An AI tool analyzes biopsy images. To determine the type and severity of cancer, pathologists typically examine thin slices ...

A recent study unveiled a key enzyme involved in producing selenoproteins, opening new strategies for treating certain types of cancer in children.

Although the future of AI in health care is somewhat predictable, its current application suggests the delivery of patient ...